SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

72,308.93 715.69
( 1.00%)

Global Indices

Nasdaq

51,245.91 45.04
(0.09%)

Dow Jones

7,786.38 -36.39
(-0.47%)

Hang Seng

69,343.08 -692.63
(-0.99%)

Nikkei 225

10,441.54 -16.96
(-0.16%)

Forex

USD-INR

96.67 0.30
(0.31%)

EUR-INR

108.31 -0.02
(-0.02%)

GBP-INR

127.86 0.18
(0.14%)

JPY-INR

0.61 0.00
(0.24%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Natco Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524816

INE987B01026

501.202063

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NATCOPHARM

17.51

15614.97

EPS(TTM)

Face Value()

Div & Yield %

45.47

0.57

Back

Panchmahal Steel reports standalone net loss of Rs 2.12 crore in the March 2026 quarter

May 25,2026

Net Loss of Panchmahal Steel reported to Rs 2.12 crore in the quarter ended March 2026 as against net loss of Rs 2.03 crore during the previous quarter ended March 2025. Sales rose 16.17% to Rs 105.96 crore in the quarter ended March 2026 as against Rs 91.21 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 2.26 crore in the year ended March 2026 as against net profit of Rs 3.33 crore during the previous year ended March 2025. Sales rose 0.30% to Rs 384.24 crore in the year ended March 2026 as against Rs 383.10 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	105.96	91.21	16	384.24	383.10	0
OPM %	3.56	0.11	-	2.90	4.05	-
PBDT	2.94	-0.68	LP	8.72	12.62	-31
PBT	0.93	-2.70	LP	0.74	4.56	-84
NP	-2.12	-2.03	-4	-2.26	3.33	PL

72,308.93 715.69 ( 1.00%)

51,245.91 45.04 (0.09%)

7,786.38 -36.39 (-0.47%)

69,343.08 -692.63 (-0.99%)

10,441.54 -16.96 (-0.16%)

96.67 0.30 (0.31%)

108.31 -0.02 (-0.02%)

127.86 0.18 (0.14%)

0.61 0.00 (0.24%)